Based on these data, the Food and Drug Administration approved obe-cel for the treatment of relapsed or refractory B-cell ALL in adult patients in Nov. 2024. Additional findings from the study ...

More Canadian employees are finding themselves drawn to the idea of taking an ‘adult gap year’ – an ... tugged at the right shoulder of his red T-shirt and fiddled with some strands of ...